Literature DB >> 19087875

Extracellular matrix turnover and outflow resistance.

Kate E Keller1, Mini Aga, John M Bradley, Mary J Kelley, Ted S Acott.   

Abstract

Normal homeostatic adjustment of elevated intraocular pressure (IOP) involves remodeling the extracellular matrix (ECM) of the trabecular meshwork (TM). This entails sensing elevated IOP, releasing numerous activated proteinases to degrade existing ECM and concurrent biosynthesis of replacement ECM components. To increase or decrease IOP, the quantity, physical properties and/or organization of new components should be somewhat different from those replaced in order to modify outflow resistance. ECM degradation and replacement biosynthesis in the outflow pathway must be tightly controlled and focused to retain the complex structural organization of the tissue. Recently identified podosome- or invadopodia-like structures (PILS) may aid in the focal degradation of ECM and organization of replacement components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19087875      PMCID: PMC2700052          DOI: 10.1016/j.exer.2008.11.023

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  95 in total

1.  TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).

Authors:  M Kashiwagi; M Tortorella; H Nagase; K Brew
Journal:  J Biol Chem       Date:  2001-01-23       Impact factor: 5.157

Review 2.  Shedding light on ADAM metalloproteinases.

Authors:  Ari-Pekka J Huovila; Anthony J Turner; Markku Pelto-Huikko; Iivari Kärkkäinen; Rebekka M Ortiz
Journal:  Trends Biochem Sci       Date:  2005-07       Impact factor: 13.807

Review 3.  Proteases in eye development and disease.

Authors:  Michael A Wride; Jenny Geatrell; Jeremy A Guggenheim
Journal:  Birth Defects Res C Embryo Today       Date:  2006-03

4.  Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching.

Authors:  Kate E Keller; Mary J Kelley; Ted S Acott
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

5.  The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.

Authors:  Magdalini Rapti; Susan J Atkinson; Meng-Huee Lee; Andrew Trim; Marcia Moss; Gillian Murphy
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

6.  Effect of hyaluronan on MMP expression and activation.

Authors:  N Isnard; J M Legeais; G Renard; L Robert
Journal:  Cell Biol Int       Date:  2001       Impact factor: 3.612

7.  TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.

Authors:  Debra L Fleenor; Allan R Shepard; Peggy E Hellberg; Nasreen Jacobson; Iok-Hou Pang; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

Review 8.  Changes in aqueous humor dynamics with age and glaucoma.

Authors:  B'Ann True Gabelt; Paul L Kaufman
Journal:  Prog Retin Eye Res       Date:  2005-09       Impact factor: 21.198

9.  CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.

Authors:  Hidetoshi Mori; Taizo Tomari; Naohiko Koshikawa; Masahiro Kajita; Yoshifumi Itoh; Hiroshi Sato; Hideaki Tojo; Ikuo Yana; Motoharu Seiki
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

10.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

View more
  129 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  Hic-5 Regulates Actin Cytoskeletal Reorganization and Expression of Fibrogenic Markers and Myocilin in Trabecular Meshwork Cells.

Authors:  Padmanabhan Paranji Pattabiraman; Ponugoti Vasantha Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

Review 3.  Role of microRNAs in the trabecular meshwork.

Authors:  Pedro Gonzalez; Guorng Li; Jianming Qiu; Jing Wu; Coralia Luna
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-02       Impact factor: 2.671

4.  Intraocular pressure regulation: findings of pulse-dependent trabecular meshwork motion lead to unifying concepts of intraocular pressure homeostasis.

Authors:  Murray A Johnstone
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-21       Impact factor: 2.671

5.  Gene therapy strategies in glaucoma and application for steroid-induced hypertension.

Authors:  Teresa Borrás
Journal:  Saudi J Ophthalmol       Date:  2011-05-08

6.  Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.

Authors:  Rosana Gerometta; Sandeep Kumar; Shaily Shah; Larry Alvarez; Oscar Candia; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-03       Impact factor: 4.799

Review 7.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

8.  Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cells.

Authors:  Mark S Filla; Kaylee D Dimeo; Tiegang Tong; Donna M Peters
Journal:  Exp Eye Res       Date:  2017-08-30       Impact factor: 3.467

9.  RhoA GTPase-induced ocular hypertension in a rodent model is associated with increased fibrogenic activity in the trabecular meshwork.

Authors:  Padmanabhan P Pattabiraman; Tommy Rinkoski; Eric Poeschla; Alan Proia; Pratap Challa; Ponugoti V Rao
Journal:  Am J Pathol       Date:  2014-12-12       Impact factor: 4.307

10.  Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.

Authors:  Maria-Grazia Spiga; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.